Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To determine if a specific immunomodulatory intervention reduces progression of COVID-19-related disease to organ failure or death, compared to standard of care (SoC). TRIAL DESIGN: Randomised, parallel 3-arm (1:1:1 ratio), open-label, Phase IV platform trial of immunomodulatory therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Spoorthy, Fisk, Marie, Kostapanos, Michalis, Banham-Hall, Edward, Bond, Simon, Hernan-Sancho, Elena, Norton, Sam, Cheriyan, Joseph, Cope, Andrew, Galloway, James, Hall, Frances, Jayne, David, Wilkinson, Ian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341462/
https://www.ncbi.nlm.nih.gov/pubmed/32641154
http://dx.doi.org/10.1186/s13063-020-04535-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341462/
https://www.ncbi.nlm.nih.gov/pubmed/32641154
http://dx.doi.org/10.1186/s13063-020-04535-4

Ejemplares similares